Durability of rilpivirine- versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy

Luchino Chessa;
2021-01-01

Abstract

Comparisons between rilpivirine (RPV) and integrase strand transfer inhibitors (INSTIs) in antiretroviral therapy (ART)-naïve HIV-infected individuals are currently lacking. Aim of the study was to compare, in an observational cohort setting, the durability of treatment of RPV- and INSTI-based first-line regimens.
2021
Inglese
58
4
106406
8
WOS:000724608700008
2-s2.0-85113811727
34293454
Esperti anonimi
internazionale
scientifica
Antiretroviral naïve; Dolutegravir; Elvitegravir; Raltegravir; Rilpivirine; Single tablet regimen
sì
Roberta, Gagliardini; Nicola, Gianotti; Franco, Maggiolo; Alessandro, Cozzi-Lepri; Andrea, Antinori; Silvia, Nozza; Giuseppe, Lapadula; Andrea, De Luc ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
16
reserved
Files in This Item:
File Size Format  
IJAA 2021.pdf

Solo gestori archivio

Type: versione post-print
Size 600.21 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
600.21 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie